TriLogic Pharma Overview

  • Founded
  • 2000
Founded
  • Status
  • Private
  • Latest Deal Type
  • Angel
  • Latest Deal Amount
  • $638K
Latest Deal Amount

TriLogic Pharma General Information

Description

Developer a liquid-to-gel drug delivery platform for animal and human. The company offers antibiotic gel that prevents bacterial colonies from forming, a common problem with wounded animals.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Pharmaceuticals
Primary Office
  • 4 Peachwood Drive
  • Tallassee, AL 36078
  • United States
+1 (866) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

TriLogic Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Angel (individual) 01-Aug-2012 $638K 00.000 Completed Generating Revenue
3. Convertible Debt 02-Apr-2010 00000 00.000 Completed Generating Revenue
2. Angel (individual) 20-May-2009 $1.6M $2M Completed Generating Revenue
1. Seed Round 31-Jan-2008 $400K $400K Completed Generating Revenue
To view TriLogic Pharma’s complete valuation and funding history, request access »

TriLogic Pharma Executive Team (3)

Name Title Board Seat Contact Info
James Harwick Co-Founder, President, Chief Executive Officer & Board Member
Wesley Heaton Co-Founder, Chief Operating Officer & Vice President
Hemant Alur Ph.D Co-Founder, Chief Scientific Officer of R&D, Vice President & Board Member
To view TriLogic Pharma’s complete executive team members history, request access »

TriLogic Pharma Board Members (3)

Name Representing Role Since
Hemant Alur Ph.D TriLogic Pharma Co-Founder, Chief Scientific Officer of R&D, Vice President & Board Member 000 0000
James Harwick TriLogic Pharma Co-Founder, President, Chief Executive Officer & Board Member 000 0000
Mark Traylor Self Board Member 000 0000
To view TriLogic Pharma’s complete board members history, request access »